Mira Pharmaceuticals (MIRA) Debt Ratio (2022 - 2023)

Mira Pharmaceuticals (MIRA) posted Debt Ratio of 0.47 for Q2 2023, up 203.96% sequentially from 0.16 in Q4 2022.

Mira Pharmaceuticals (MIRA) Debt Ratio (2022 - 2023) Analysis & Trends

Mira Pharmaceuticals (MIRA) has 2 years of Debt Ratio data on file, last reported at 0.47 in Q2 2023.

Quarterly Debt Ratio changed N/A year-over-year to 0.47 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was 0.47 (changed N/A YoY) and the FY2022 annual result came in at 0.16, changed N/A from the prior year.
Debt Ratio rose to 0.47 in Q2 2023 per MIRA's latest filing, from 0.16 in the prior quarter.
The five-year high for Debt Ratio was 0.47 in Q2 2023, with the low at 0.16 in Q4 2022.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn	0.37
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn	0.27
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn	0.47
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn	-0.21
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn	0.38
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn	0.62
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn	0.39
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn	0.31
9	Novartis Ag	113.45 Bn	113.67 Bn	-	-
10	Mira Pharmaceuticals	22.51 Mn	11.48 Mn	-	-

Historic Data

Download Data

Date	Value
Jun 30, 2023	0.47
Dec 31, 2022	0.16